Washington, DC — Protect Our Care is releasing a new report detailing pharmaceutical companies’ sky-high revenues as they continue charging unaffordable prices to patients. In total, the 16 top companies reported $176.7 billion in total global revenue for the third quarter, and have rewarded shareholders by announcing dividend payments and stock buybacks totalling $26.8 billion. According to the r...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
